Corient Private Wealth’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-15,000
| Closed | -$21.6K | – | 2563 |
|
|
2025
Q1 | $21.6K | Sell |
15,000
-35,745
| -70% | -$51.5K | ﹤0.01% | 2249 |
|
|
2024
Q4 | $112K | Sell |
50,745
-108,702
| -68% | -$239K | ﹤0.01% | 2207 |
|
|
2024
Q3 | $263K | Sell |
159,447
-23,053
| -13% | -$38K | ﹤0.01% | 2044 |
|
|
2024
Q2 | $405K | Buy |
+182,500
| New | +$405K | ﹤0.01% | 1751 |
|
|
2023
Q2 | – | Sell |
-17,334
| Closed | -$27.6K | – | 2082 |
|
|
2023
Q1 | $27.6K | Buy |
+17,334
| New | +$27.6K | ﹤0.01% | 1948 |
|